ipilimumab,nivolumab
bms
['niche-2', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'ipilimumab']
the winner waterfall plot/ is esmo22 in 1 slide /by(myriam chalaby) she found that all cases(107) with msi-h crc waiting for surgery respond to immunotherapy (nivilumab and ipilimumab) and in2/3cancer dissappeared before surgery time (niche-2 study)great #esmo22 
MD,Biochemical&Molecular.Genetic
                             MOH.Kuwait
                        KCCC/KMGC/NBS